Dr. Lal Pathlabs Ltd. Conference Calls and Earnings Call Transcripts

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith Transcript of Conference Call of the Company held on Monday, March 30, 2020 at 6:00 PM IST to discuss Business Updates.

Earnings Call Transcript - Opening Remarks

we continue to deliver another quarter of strong performance on the back of our well-diversified hub-and-spoke model and our undeterred commitment to drive quality in our service industry. These two have been the key pillars driving our growth in the last decade. At the macro level, our country continues to remain underserved in terms of high quality, reliable diagnostics services whereas there is an abundance of laboratories all over.

According to one estimate, there are more than 1 lakh diagnostic laboratories in the country. At Dr. Lal PathLabs, we continue to offer a high quality and consistent service experience for our customers. Having said that, we are also continuously working on further enhancing our quality and service delivery for our customers to provide an improved user experience every time they visit any of our centers. We continue to provide reliable and high quality diagnostic services to our customers at an affordable price while also widening our test menu and a geographical presence.

Our higher patient volumes and sample growth is a testimony to this. As a leading national diagnostics services player, we have the benefit of experience, scale, certified infrastructure, operational and clinical best practices and an extensive test menu. While we aim to strengthen these parameters, we will look at intensifying presence of both key geographies where we are strong and play places where we are in the ramp up phase.

Click pdf to read full transcript

Dear Sir/Madam, Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith Financial Results Conference Call Transcript of the Company for Q2 & H1 FY20. We request you to please take the same on record.

Dear Sir/Madam, This is in furtherance to our letter dated August 28, 2019, through which we had sent Financial Results Conference Call Transcript of the Company for Q1 FY20. In this respect, kindly find attached a revised copy of Company''s transcript for Q1 FY20. A data point in the document has been updated on page 13; to reflect the correct number of employees -which stands at 4,400. We request you to kindly take the same on record.

Dear Sir/Madam, Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith Financial Results Conference Call Transcript of the Company for Q1 FY20. We request you to please take the same on record.

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Financial Results Conference Call Transcript of the Company for Q4 & FY19 is attached herewith.

Dear Sir/Madam, Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith Financial Results Conference Call Transcript of the Company for Q3 & 9M FY19. We request you to please take the same on record.

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith Financial Results Conference Call Transcript of the Company for Q2 & H1 FY19.

Dear Sir/Madam, Pursuant to Reg. 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith Financial Results Conference Call Transcript of the Company for Q1 FY19. We request you to please take the same on record.

Financial Results Conference Call Transcript of the Company for Q4 FY18 is attached herewith.